Biocon and Mylan have hit another manufacturing snag on their march toward an FDA nod for their copy of Sanofi's blockbuster Lantus.  

China has closed thousands of manufacturing plants as it tries to reduce air pollution, and one pharma company says it has created supply problems.

After a year of remediation, an Indian drugmaker has worked its way out from under an FDA warning letter issued for its sterile injectables operation.

A recently released FDA document shows that Pfizer's troubled fill-finish plant in Kansas was cited for continuing to repeat mistakes already cited by the…

Celgene has completed the first phase of a new manufacturing facility to produce the CAR-T drug candidate it is developing with partner Bluebird Bio.

The FDA has issued a warning letter to a Bayer finished products plant in Germany, where it says poor cleaning led to product cross-contamination.

A Merck manufacturing site in Ireland that was slated to close has been saved by the drugmaker’s hot-selling cancer drug Keytruda.

ImmunoGen will turn to contractors for its manufacturing needs, a move that will mean a small facility will close and 20 workers will be let go.